NEUROD1 and small cell lung carcinoma: (53) analyzed 174 SCLC samples using IHC and found that ASCL1 was dominantly expressed in 69% samples, NEUROD1 in 17%, and POU2F3 in 7%, whereas no sample exhibited positive expression of YAP1 (H-score > 10), which was conflict to RNA-seq analysis.